Conformis Hopes to Rekindle Product Sales in 2022 Company Revenue The company grew 45% in 2021 on the strength of non-recurring royalty payments, but product revenue remains well below pre-pandemic levels. Mar 04, 2022
ATEC Sets Sights on Decade of Supremacy Company Revenue The company grew nearly 70% in 2021, making it one of the premier growth stories in medtech. ATEC is bullish on its future prospects. Mar 03, 2022
SI-BONE Investments Set to Pay Off in 2022 Company Revenue The company grew over 20% in 2021 and expects similar growth in 2022 due to its expanded portfolio and exclusive payor coverage. Mar 02, 2022
Orthofix Views 2022 As Inflection Point for Growth Company Revenue The company grew 1% over its 2019 total and sees this year as a bridge to consistent mid-single-digit growth in the future. Feb 28, 2022
Enrollment Complete in Cerapedics’ Bone Graft Study Orthobiologics The ASPIRE study is intended to evaluate use of P-15L Bone Graft in TLIF in 290 patients with degenerative disc disease. Feb 24, 2022
Orthopedic Design Engineers Will Convene for OMTEC Manufacturing Expo CEOs of CONMED and DJO Global will be Keynote Panelists — Supply Chain Disruption, Custom Implants, Next-Gen Biomaterials, Additive and Personal Development Among Education Topics. Feb 22, 2022
Smith+Nephew Announces New Chief Executive Officer Company Revenue Dr. Deepak Nath has been appointed as the company’s new Chief Executive Officer, succeeding Roland Diggelmann. Feb 22, 2022
Amplitude Surgical Growth Spurred by Foot and Ankle Segment Company Revenue The company's knee and hip replacement sales remain impacted by surgical restrictions, but its foot and ankle line continued its ascent. Feb 21, 2022
Zimmer Biomet Lowers Expectations for 2022 Company Revenue The company grew in the low double digits for 2021 compared to 2020. but expects 2022 to be flat at best, given the market environment. Feb 08, 2022
ConMed Foresees Hospital Staffing Challenges in 2022 Company Revenue The company expects to grow in the mid-single-digits to low double-digits in 2022 but cautioned the year is off to a challenging start. Jan 27, 2022